Rinnekin post on Stock twits. Bell Potter estimates the paxalisib trial arm of GBM AGILE, is 50% enrolled at this point in time (December 2021). Merry Christmas and good luck to the GBM patients using the paxalisib pill.
Regards.
KZA Price at posting:
$1.15 Sentiment: Buy Disclosure: Held